Immunovant, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | — | $852.6M | $902.1M |
| Jun 2026 | — | $735.4M | $797.8M |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | — | $852.6M | $902.1M |
| Jun 2026 | — | $735.4M | $797.8M |